Wells Fargo Maintains Overweight on MetLife, Raises Price Target to $95

Benzinga Newsdesk www.benzinga.com Positive 56.1%

Neg 0% Neu 0% Pos 56.1%

Wells Fargo analyst Wesley Carmichael maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $90 to $95.